Analyst, Investment Banking - Mergers and Acquisitions

TD•Dallas, TX

11d•$110,000 - $135,000•Onsite

About The Position

The Investment Banking Analyst provides financial, strategic, and execution support on mergers and acquisitions involving biotechnology and life sciences companies. The role is highly analytical, with a primary focus on financial modeling, valuation, transaction analysis, due diligence, and the preparation of materials for live M&A engagements.

Requirements

Advanced Excel proficiency and the ability to build, audit, and explain complex biotechnology operating and M&A models from first principles
Strong understanding of biotechnology valuation, drug development, clinical and regulatory risk, M&A structures, and transaction mechanics
Ability to translate scientific, clinical, commercial, and transaction information into defensible assumptions and clear client conclusions
High standards of analytical rigor, ownership, and execution across multiple live M&A workstreams
Undergraduate degree with strong academic performance in Finance, Accounting, Economics, Mathematics, Engineering, Biology, Chemistry, Biochemistry, or a related field
0-3 years of relevant experience in investment banking, transaction advisory, equity research, healthcare investing, or a related analytical role
Demonstrated interest in biotechnology, pharmaceuticals, healthcare, and M&A
Advanced Excel and PowerPoint proficiency; applicable securities licenses required

Responsibilities

Works as an integral member of M&A transaction teams advising biotechnology, pharmaceutical, and life sciences clients
Builds and maintains complex operating, valuation, and transaction models, including DCF, probability-adjusted pipeline, sum-of-the-parts, merger, accretion / dilution, purchase price allocation, and scenario analyses
Develops biotechnology-specific forecasts incorporating clinical timelines, probability of success, market opportunity, pricing, patent exclusivity, competition, and product lifecycle assumptions
Evaluates potential acquirers, targets, transaction structures, strategic alternatives, consideration mixes, financing assumptions, ownership, dilution, and pro forma financial impacts
Analyzes public and private companies, including financial performance, capital structure, liquidity, clinical pipelines, regulatory milestones, commercial outlook, and strategic fit
Conducts detailed diligence across therapeutic areas, clinical data, regulatory pathways, intellectual property, market dynamics, competitive positioning, and M&A precedents
Prepares valuation materials, board presentations, management presentations, process letters, bid analyses, transaction summaries, and other materials for live M&A engagements
Coordinates financial, legal, regulatory, commercial, and scientific diligence and maintains transaction models, data rooms, trackers, and other execution workstreams
Maintains exceptional accuracy, responsiveness, judgment, confidentiality, and attention to detail under demanding transaction timelines